A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis. Source: International Congress 2018 – Hot topics in non-invasive ventilation Year: 2018
The long-term effect of an exercise and diet intervention in asthma patients: a 1-year follow-up on a randomised controlled trial Source: ERJ Open Res, 5 (2) 00032-2019; 10.1183/23120541.00032-2019 Year: 2019
Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a one-year follow-up randomised, controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002
One-year follow-up of asthma patients in a randomised controlled trial of high-intensity training. Are there lasting effects? Source: International Congress 2018 – Clinical markers of asthma Year: 2018
Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial Source: Eur Respir J 2001; 17: 206-213 Year: 2001
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials Source: Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020 Year: 2021
RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021
Outcomes reported in pneumonia randomized controlled trials Source: Virtual Congress 2021 – Pneumonia Year: 2021
Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017 Year: 2017
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT? Source: ERJ Open Res 2016: 00055-2016 Year: 2016
Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial Source: Eur Respir J, 54 (5) 1900983; 10.1183/13993003.00983-2019 Year: 2019
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019 Year: 2019
Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
COVID-19 pneumonia and clinical follow-up: results of a prospective cohort Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021
Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019
A self-management programme for COPD: a randomised controlled trial Source: Eur Respir J 2014; 44: 1538-1547 Year: 2014
No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020 Year: 2020
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis Source: Eur Respir J 2014; 43: 1114-1123 Year: 2014